# HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies

> **NCT03213314** · NA · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 149 (actual)

## Conditions studied

- Liver Cancer
- Surgery
- Liver Regeneration
- Colorectal Cancer Metastatic

## Interventions

- **DIAGNOSTIC_TEST:** Multiparameter magnetic resonance imaging

## Key facts

- **NCT ID:** NCT03213314
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-07
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2019-10-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03213314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03213314, "HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03213314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*